These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9669647)

  • 21. High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update.
    Harnett N
    Epidemiol Infect; 1992 Dec; 109(3):463-72. PubMed ID: 1468530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.
    Taneja N; Mewara A; Kumar A; Verma G; Sharma M
    J Antimicrob Chemother; 2012 Jun; 67(6):1347-53. PubMed ID: 22410619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.
    Hansson HB; Walder M; Juhlin I
    Antimicrob Agents Chemother; 1981 Feb; 19(2):271-3. PubMed ID: 6289727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and susceptibility of Shigella species to 11 antibiotics in a Kuwait teaching hospital.
    Jamal WY; Rotimi VO; Chugh TD; Pal T
    J Chemother; 1998 Aug; 10(4):285-90. PubMed ID: 9720466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
    Cokça F; Altay G
    Mikrobiyol Bul; 1992 Oct; 26(4):333-7. PubMed ID: 1435363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing single and multi-antibiotic resistance in Shigella species isolated from shigellosis patients in Sana'a, Yemen.
    Al-Moyed KA; Harmal NS; Al-Harasy AH; Al-Shamahy HA
    Saudi Med J; 2006 Aug; 27(8):1157-60. PubMed ID: 16883444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1.
    Ambler JE; Drabu YJ; Blakemore PH; Pinney RJ
    J Antimicrob Chemother; 1993 Jun; 31(6):831-9. PubMed ID: 8360123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmid-encoded multidrug resistance: A case study of Salmonella and Shigella from enteric diarrhea sources among humans.
    Suh Yah C
    Biol Res; 2010; 43(2):141-8. PubMed ID: 21031258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
    Gulay Z; Bicmen M; Amyes SG; Yulug N
    J Chemother; 2000 Jun; 12(3):208-15. PubMed ID: 10877515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shigella and the fluorinated quinolones.
    Ballal M; Baby ; Chandran A; Mathew M; Shivananda PG
    Indian J Pathol Microbiol; 1998 Oct; 41(4):453-6. PubMed ID: 9866907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
    Abd-Elalim Eltahawy AT; Khalaf RM
    Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wide dissemination of multidrug-resistant Shigella isolates in China.
    Zhang W; Luo Y; Li J; Lin L; Ma Y; Hu C; Jin S; Ran L; Cui S
    J Antimicrob Chemother; 2011 Nov; 66(11):2527-35. PubMed ID: 21859815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
    Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
    J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic susceptibility of canine Bordetella bronchiseptica isolates.
    Speakman AJ; Dawson S; Corkill JE; Binns SH; Hart CA; Gaskell RM
    Vet Microbiol; 2000 Feb; 71(3-4):193-200. PubMed ID: 10703703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004.
    Kuo CY; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; Van PH; Chongthaleong A; Song JH; Chiu CH
    J Microbiol Immunol Infect; 2008 Apr; 41(2):107-11. PubMed ID: 18473096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.